High-intensity focused ultrasound (HIFU) for benign thyroid nodules: 2-year follow-up results
- 51 Downloads
High-intensity focused ultrasound (HIFU) is the last introduced thermal treatment of thyroid nodules. Here we evaluated the results at 24 months after HIFU.
Since 2016, HIFU was considered as a therapeutic option at our institute in patients with benign thyroid nodules presenting local symptoms. We searched in our database all patients who had undergone thyroid HIFU and selected for the study only cases followed-up for at least 24 months after the treatment. Volume reduction rate (VRR) was evaluated. A reduction above 50% defined the success of HIFU.
Thirty-one nodules of 31 patients (24 females and 7 males, median age 67 years) with median major diameter from 17 to 34 mm and estimated nodule volume of 5.48 mL were included. HIFU was performed with median power of 42 W/site (interquartile range 25–45) and median energy of 263 J/site (interquartile range 225–273). Median duration of the procedure was 6 min (interquartile range 5–7). At 2 years after HIFU, nodule volume was significantly (p < 0.0001) lower (i.e., 3.40 mL) with VRR of 43.3%, and 26 (83.9%) lesions were reduced. A reduction by at least 50% was observed at 6, 12, and 24 months in 2 (6.4%), 5 (16.1%), and 7 (22.5%) nodules, respectively. Visual analog score showed a significant improvement (p < 0.0001). No complications were recorded.
A reduction of benign thyroid nodule by more than 40% could be reached within 1 year by HIFU. Given the non-significant size increase of some lesions later, a larger study with a longer follow-up is necessary.
KeywordsThyroid Thermal ablation High-intensity focused ultrasound (HIFU)
The authors thank Riccardo Ricci CNMT and Cinzia Pezzoli CNMT who significantly contributed for all HIFU treatments.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Also, for this retrospective study, formal consent was not required.
- 1.E.J. Ha, H.K. Lim, J.H. Yoon, J.H. Baek, K.H. Do, M. Choi et al. Primary imaging test and appropriate biopsy methods for thyroid nodules: guidelines by Korean Society of Radiology and National Evidence-Based Healthcare Collaborating Agency. Korean J. Radiol. 19, 623–631 (2018)CrossRefPubMedGoogle Scholar
- 4.B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov et al. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016)CrossRefPubMedGoogle Scholar
- 12.L. Giovanella, A. Piccardo, C. Pezzoli, F. Bini, R. Ricci, T. Ruberto et al. Comparison of high intensity focused ultrasound and radioiodine for treating toxic thyroid nodules. Clin. Endocrinol. (Oxf.) 2018, in press. https://doi.org/10.1111/cen.13738
- 17.C.M. Pacella, G. Mauri, R. Cesareo, V. Paqualini, R. Cianni, P. De Feo et al. A comparison of laser with radiofrequency ablation for the treatment of benign thyroid nodules: a propensity score matching analysis. Int. J. Hyperth. 33, 911–919 (2017)Google Scholar
- 19.G. Mauri, C.M. Pacella, E. Papini, L. Solbiati, S.N. Goldberg, M. Ahmed, L.M. Sconfienza, Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid. 2019, in press. https://doi.org/10.1089/thy.2018.0604
- 20.E. Papini, C.M. Pacella, L.A. Solbiati et al. Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the Thyroid Group. Int J Hyperthermia. 2019, in press. https://doi.org/10.1080/02656736.2019.1575482